EX-99.1 2 v445895_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

 

Sapiens Reports Q2 2016 Financial Results

 

 

Holon, Israel – August 4, 2016 Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with a growing presence in the financial services sector, and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), today announced its financial results for the second quarter ended June 30, 2016.

 

Second Quarter Highlights:

 

·GAAP Revenue of $53.0 million, up 15.1% compared to $46.1 million in the second quarter of 2015.

 

·Non-GAAP revenue of $53.0 million, up 22.1% compared to $43.4 million in the second quarter of 2015.

 

·

GAAP Operating profit increased by 6.3% and totaled $6.4 million (12.1% operating margin), compared to $6.0 million (13.1% operating margin) in the second quarter of 2015. 

 

·

Non-GAAP operating profit increased by 15.3% and totaled $7.4 million (14.0% operating margin), compared to $6.4 million (14.8% operating margin) in the second quarter of 2015. 

 

·

GAAP Net income attributable to Sapiens’ shareholders totaled $5.3 million or $0.11 per diluted share, an increase of 12.9% compared to $4.7 million or $0.10 per diluted share in the second quarter last year. 

 

·

Non-GAAP net income attributable to Sapiens’ shareholders totaled $6.3 million or $0.13 per diluted share, an increase of 19.5% compared to $5.2 million or $0.11 per diluted share in the second quarter last year. 

 

·

Cash, cash equivalents and securities investments as of June 30, 2016 was $100.0 million, following the distribution of a cash dividend in the amount of $9.8 million. The company has no debt. 

 

 “We saw strong double-digit growth and improved performance across our offerings and across all of our territories, driven by strong demand from existing customers and from ramping sales from new customers. As in recent quarters, the demand for our products and services remained strong,” said Roni Al-Dor, President and CEO of Sapiens.

 

1 

 

 

 

“Overall, we improved our position in the market, and our competitive advantage in our various target markets resulted in several important wins with new customers. More importantly, we expect this momentum in sales to continue throughout the year.”

 

Mr. Al-Dor continued. “On the deal front, during the second quarter we signed a multimillion expansion with Anadolu Insurance Company, a private insurer operating in Turkey. As in many of our other strategic relationships, this win was part of a larger transformation project. We view this expansion as yet another key example of how our solutions can help our P&C client base grow and mature over time as they consolidate their multiple lines of business on a single platform, namely our IDIT software suite.

 

“In addition following the end of the second quarter, we acquired Maximum Processing, a US- P&C Solution Provider. Maximum Processing’s policy administration suite, Stingray System, services tier-4 and tier-5 P&C carriers, MGAs, TPAs and brokers. This acquisition will expand Sapiens’ overall presence in North America and expedite entry into the U.S. P&C market. We consider this acquisition consistent with our long-term growth strategy of organic growth next to M&A activity.”

  

Mr. Al-Dor concluded: “Based on the strength of our first half growth and our outlook for the remainder of the year, we are raising our guidance to 2016 full year non-GAAP revenues of $211 to $215 million, or annual growth of 18%-20%, up from prior guidance of $207 to $211 million.

 

To support this expansion in growth, we are increasing our short-term investments in R&D, delivery, sales and marketing. Also, we expect to see an impact of the British pound devaluation on our operations following the UK decision to exit the EU. We now expect full-year 2016 non-GAAP operating margins in the range of 13.5% - 14.0%, compared to our previous guidance of 15.0%-15.5%.”

 

Quarterly Results Conference Call

 

Management will host a conference call and webcast on August 4 at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results. Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

North America (toll-free): + 1-888-281-1167; International: +972-3-918-0685; UK: 0-800-917-9141

The live webcast of the call can be viewed on Sapiens’ website at: http://www.sapiens.com/investors/presentations-and-webcast/

If you are unable to join live, a replay of the call will be accessible until August 18, 2016, as follows:

North America: 1-888-269-0005; International: +972-3-925-5929.

 

A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.

 

2 

 

 

Non-GAAP Financial Measures

 

This press release contains the following non-GAAP financial measures: Non-GAAP revenue, Non-GAAP gross profit, Non-GAAP operating income, Non-GAAP net income attributed to Sapiens shareholders, Non-GAAP basic and diluted earnings per share.

 

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

 

Management of the Company does not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

 

In addition, the Company adjusted revenues and expenses, recorded under US GAAP, of pre-acquisition date in respect of acquired business from its ultimate parent company. As this transaction is between companies under common control, under US GAAP, it was accounted for under the pooling of interest method. For non-GAAP measurement purposes, the Company excludes the pre-acquisition date revenues and expenses.

 

3 

 

 

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included in the financial tables of this release.

 

The Company defines adjusted EBITDA as net profit adjusted for stock-based compensation expense, depreciation and amortization, capitalized internal-use software development costs, amortization of internal-use software development costs interest expense, compensation expenses related to acquisition, acquisition related costs, pre-acquisition revenues and expenses accounted under pooling of interest method, provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business. The Company uses Adjusted EBITDA as a measurement of its operating performance because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflect an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business.

 

About Sapiens

 

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector. We offer core, end-to-end solutions to the global general insurance, property and casualty, life, pension and annuities, and retirement markets, as well as business decision management software. We have a track record of over 30 years in delivering superior software solutions to more than 200 financial services organizations. The Sapiens team of approximately 1,800 professionals operates through our fully-owned subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific. For more information: www.sapiens.com.

 

Forward-Looking Statement

 

Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.

 

4 

 

 

These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2015, and subsequent reports and registration statements filed periodically with the Securities and Exchange Commission.

 

Investors and Media Contact:
Yaffa Cohen-Ifrah

Chief Marketing Officer and Head of Corporate Communications

Sapiens International

U.S. Mobile: +1-201-250-9414

Mobile: +972-54-9099039

Email: yaffa.cohen-ifrah@sapiens.com

 

5 

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts) 

    Three months ended     Six months ended 
   June 30,   June 30, 
   2016   2015*   2016   2015* 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
 Revenue   53,030    46,066    102,597    89,927 
 Cost of revenue   31,781    28,166    61,388    54,616 
                     
 Gross profit   21,249    17,900    41,209    35,311 
                     
 Operating Expenses:                    
 Research and development, net   4,001    2,385    7,254    5,006 
 Selling, marketing, general and administrative   10,841    9,486    21,297    18,478 
 Total operating expenses   14,842    11,871    28,551    23,484 
                     
 Operating income   6,407    6,029    12,658    11,827 
                     
 Financial expense (income), net   (326)   14    (406)   344 
 Taxes and other expenses, net   1,468    1,213    2,926    1,894 
                     
                     
 Net income   5,265    4,802    10,138    9,589 
                     
 Attributable to non-controlling interest   (68)   77    (82)   135 
                     
 Net income attributable to Sapiens' shareholders   5,333    4,725    10,220    9,454 
                     
                     
 Basic earnings per share   0.11    0.10    0.21    0.20 
                     
 Diluted earnings per share   0.11    0.10    0.21    0.19 
                     
                     
Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)   48,948    47,910    48,883    47,809 
                     
Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)   49,759    49,213    49,659    49,098 

 

*Including consolidation of Insseco, commencing December 31, 2014.

 

6 

 

 

Summary of Non-GAAP Financial Information
U.S. dollars in thousands (except per share amounts)

 

   Three months ended
June 30,
   Six months ended
June 30,
 
   2016   2015   2016   2015 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                                 
Revenues   53,030    100%   43,436    100%   102,597    100%   84,450    100%
Gross Profit   22,726    42.9%   18,568    42.7%   44,300    43.2%   36,246    42.9%
Operating profit   7,426    14.0%   6,441    14.8%   14,774    14.4%   12,229    14.5%
Net income to shareholders   6,251    11.8%   5,230    12.0%   12,237    11.9%   9,957    11.8%
Adjusted EBITDA   8,082    15.2%   6,900    15.9%   16,037    15.6%   13,078    15.5%
                                         
Basic earnings per share   0.13         0.11         0.25         0.21      
Diluted earnings per share   0.13         0.11         0.25         0.20      

 

 

Non-GAAP revenues by geographic breakdown
U.S. dollars in thousands

 

   Q2 2016   Q1 2016   Q4 2015   Q3 2015   Q2 2015 
                          
North America   17,601    16,041    16,767    16,571    14,294 
Europe   26,124    28,421    26,439    24,084    23,743 
APAC   9,305    5,105    5,468    5,484    5,399 
                          
Total   53,030    49,567    48,674    46,139    43,436 

 

7 

 

 

Adjusted EBITDA Calculation
U.S. dollars in thousands

 

   Three months ended   Six months ended 
   June 30,   June 30, 
   2016   2015   2016   2015 
                 
GAAP operating profit   6,407    6,029    12,658    11,827 
                     
Non GAAP adjustments:                    
Amortization of capitalized software   1,256    1,135    2,665    2,350 
Amortization of other intangible assets   495    608    1,006    1,129 
Capitalization of software development   (1,396)   (1,553)   (2,780)   (2,865)
Stock-based compensation   482    290    940    568 
Compensation related to acquisition and acquisition related costs   182    71    285    71 
Adjustments of pre-acquisition revenues and expenses accounted under pooling of interest method   -    (139)   -    (851)
                     
Non GAAP operating profit   7,426    6,441    14,774    12,229 
                     
Depreciation   656    459    1,263    849 
                     
Adjusted EBITDA   8,082    6,900    16,037    13,078 

 

8 

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

 

   Three months ended   Six months ended 
   June 30,   June 30, 
   2016   2015   2016   2015 
 GAAP revenue   53,030    46,066    102,597    89,927 
Adjustments of pre-acquisition revenue accounted under pooling of interest method        (2,630)        (5,477)
Non-GAAP revenue   53,030    43,436    102,597    84,450 
                     
                     
GAAP gross profit   21,249    17,900    41,209    35,311 
Revenue adjustment   -    (2,630)   -    (5,477)
Amortization of capitalized software   1,256    1,135    2,665    2,350 
Amortization of other intangible assets   221    215    426    409 
Adjustments of pre-acquisition cost of revenue accounted under pooling of interest method   -    1,948    -    3,653 
Non-GAAP gross profit   22,726    18,568    44,300    36,246 
                     
                     
GAAP operating income   6,407    6,029    12,658    11,827 
Gross profit adjustments   1,477    668    3,091    935 
Capitalization of software development   (1,396)   (1,553)   (2,780)   (2,865)
Amortization of other intangible assets   274    393    580    720 
Stock-based compensation   482    290    940    568 
Compensation related to acquisition and acquisition related costs   182    71    285    71 
Adjustments of pre-acquisition operating expenses accounted under pooling of interest method   -    543    -    973 
Non-GAAP operating income   7,426    6,441    14,774    12,229 
                     
                     
GAAP net income attributable to Sapiens' shareholders   5,333    4,725    10,220    9,454 
Operating income adjustments   1,019    412    2,116    402 
Adjustment to redeemable non-controlling interest   37    96    103    96 
Adjustments of pre-acquisition financial and tax expenses accounted under pooling of interest method   -    24    -    166 
Other   (138)   (27)   (202)   (161)
Non-GAAP net income attributable to Sapiens' shareholders   6,251    5,230    12,237    9,957 
                     
                     
Non-GAAP basic earnings per share   0.13    0.11    0.25    0.21 
                     
Non-GAAP diluted earnings per share   0.13    0.11    0.25    0.20 
                     
                     
Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)   48,948    47,910    48,883    47,809 
Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)   49,759    49,213    49,659    49,098 

 

9 

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. Dollars in thousands

 

   June 30,   December 31, 
   2016   2015 
   (unaudited)   (unaudited) 
         
ASSETS        
         
 CURRENT ASSETS:          
Cash and cash equivalents   60,271    54,351 
Trade receivables, net   31,274    29,761 
Other receivables and prepaid expenses   6,188    5,455 
Marketable securities   27,677    8,776 
           
 Total current assets   125,410    98,343 
           
 LONG-TERM ASSETS:          
Marketable securities   12,091    30,875 
Property and equipment, net   7,628    5,675 
Severance pay fund   4,554    5,551 
Other intangible assets, net   26,808    27,540 
Other long-term assets   5,189    4,252 
Goodwill   70,626    70,035 
           
 Total long-term assets   126,896    143,928 
           
 TOTAL ASSETS   252,306    242,271 
           
 Liabilities and Equity          
           
 CURRENT LIABILITIES:          
 Trade payables   7,403    4,721 
 Accrued expenses and other liabilities   30,767    32,012 
 Deferred revenue   14,430    10,268 
           
 Total current liabilities   52,600    47,001 
           
 LONG-TERM LIABILITIES:          
 Other long-term liabilities   7,709    6,414 
 Accrued severance pay   5,670    6,662 
           
 Total long-term liabilities   13,379    13,076 
           
           
REDEEMABLE NON-CONTROLLING INTEREST   385    385 
           
 EQUITY   185,942    181,809 
           
 TOTAL LIABILITIES AND EQUITY   252,306    242,271 

 

10 

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOW
U.S. dollars in thousands

 

  

For the six months ended

June 30,

 
    2016    2015*
    (unaudited)    (unaudited) 
Cash flows from operating activities:          
Net income   10,138    9,589 
Reconciliation of net income to net cash provided by operating activities:          
Depreciation and amortization   4,934    4,462 
Amortization of premium and accrued interest on marketable securities   (262)   (184)
Stock-based compensation related to options issued to employees   940    568 
           
Net changes in operating assets and liabilities, net of amount acquired:          
Trade receivables   (1,599)   1,411 
Deferred tax assets   52    1,873 
Other operating assets   (980)   378 
Trade payables   1,574    1,294 
Other operating liabilities   (50)   (618)
Deferred revenues   4,401    1,502 
Severance pay   (10)   (304)
           
Net cash provided by operating activities   19,138    19,971 
           
Cash flows from investing activities:          
Purchase of property and equipment   (2,013)   (1,316)
Purchase of marketable securities, net of interest received   (2,359)   (6,524)
Proceeds from sales of marketable securities   2,677    1,015 
Payments for business acquisition, net of cash acquired   -    (1,736)
Capitalized software development costs   (2,780)   (2,865)
Restricted cash   -    (1,712)
           
Net cash used in investing activities   (4,475)   (13,138)
           
Cash flows from financing activities:          
Proceeds from employee stock options exercised   686    501 
Payment to shareholders in respect of acquisition   (1,440)   3,319 
Distribution of dividend   (8,809)   (6,486)
           
Net cash used in financing activities   (9,563)   (2,666)
           
Effect of exchange rate changes on cash and cash equivalents   820    494 
           
Increase in cash and cash equivalents   5,920    4,661 
Cash and cash equivalents at the beginning of period   54,351    47,400 
           
Cash and cash equivalents at the end of period   60,271    52,061 

 

*Including consolidation of Insseco, commencing December 31, 2014.

 

11